Velg din region

Velg regionen som passer best for din plassering eller dine preferanser.

International

Velg ditt nettstedsspråk

Denne innstillingen kontrollerer språket for brukergrensesnittet, inkludert knapper, menyer og all tekst på nettstedet. Velg ditt foretrukne språk for best brukeropplevelse.

Velg språk for stillingsannonser

Velg språkene for stillingsannonser du vil se. Denne innstillingen bestemmer hvilke stillingsannonser som vises for deg.

DIACCURATE

Paris, Frankrike

Besøk nettside

Om arbeidsgiveren

Diaccurate is a spin off from the Pasteur Institute in Paris, France. We work on a new enzymatic mechanism involved in the control of immune responses against HIV and other pathogens. Involvement of this mechanism in the control of tumor growth is also under study. We have discovered in the plasma of immunodeficient patients, a new molecule named RIF (for “Refractory state Inducing Factor”) which by modifying their membrane blocks specifically CD4 lymphocytes responses. Inhibitory monoclonal antibody neutralizing RIF has been characterized and clinical trials should start in 2018.